Taking It Personally
March 07, 2014 – Laura Beil
Advocacy in Action
March 08, 2014 – Jane Hill
Can a Pill Prevent Cancer?
March 08, 2014 – Erik Ness
New Requirements for Patients and Survivors Needs
March 08, 2014 – Katy Human
How Survivors Can Take Action
March 08, 2014
Promises to Keep
March 06, 2014 – Tracy Stewart
Aiming to Improve Quality of Cancer Care
March 06, 2014 – Shelley Fuld Nasso
Confirmation of Lycopene's Benefits Remains Elusive
March 06, 2014 – Deborah Tolmach Sugerman
Taking Immune Action Against Lung Cancer
March 08, 2014 – Heather L. Van Epps, PhD
Pipeline
March 08, 2014 – Lindsay Ray
Preserving Security with Electronic Health Portals
March 06, 2014 – Charlotte Huff
The "To Do" List to Pass On to Well-Meaning Friends
March 08, 2014 – Don Vaughan
Choosing Quality Care
March 08, 2014 – Len Lichtenfeld, MD
Mobile App Delivers Helpful Tips to Minimize Side Effects
March 08, 2014
Legislations Could Benefit Family Caregivers
March 08, 2014 – Lena Huang
Exercise Improves Joint Pain Associated with Aromatase Inhibitors
March 08, 2014 – Jon Garinn
Moving Beyond Cancer to Wellness
March 08, 2014
Breast Cancer Prevention Study Focuses on Anti-Hormone Therapy
March 08, 2014 – Jon Garinn
Correspondent Amy Robach Receives Treatment
February 28, 2014 – Lindsay Ray
No Link Between Fertility Treatment and Overall Risk of Childhood Cancer
March 07, 2014 – Katherine Lagomarsino
Alzheimer's Disease and Cancer
March 06, 2014 – Sonya Collins
Research Updates
February 28, 2014 – Elizabeth Whittington
Genetics Leading the Way in Lung Cancer Treatment
March 05, 2014 – Debu Tripathy, MD
Letters From Readers
March 08, 2014
For Many, Caregiving Leads to Advocacy
March 07, 2014 – Jane Hill
Calming Chronic Inflammation
March 07, 2014 – Erik Ness
Making the Most Out of Your Patient Portal
March 07, 2014 – Charlotte Huff
Disclosing a Cancer Diagnosis Takes Time and Tact
March 05, 2014 – Don Vaughan
National Guidelines Aim to Make Life Better After Cancer
March 07, 2014 – Katy Human
Research Reveals New Frontiers in Lung Cancer
March 06, 2014 – Heather L. Van Epps, PhD
Biomarkers Help Patients Make Better Medical Decisions
March 06, 2014 – Laura Beil
Taking It Personally
March 07, 2014 – Laura Beil
Advocacy in Action
March 08, 2014 – Jane Hill
Can a Pill Prevent Cancer?
March 08, 2014 – Erik Ness
New Requirements for Patients and Survivors Needs
March 08, 2014 – Katy Human
How Survivors Can Take Action
March 08, 2014
Promises to Keep
March 06, 2014 – Tracy Stewart
Aiming to Improve Quality of Cancer Care
March 06, 2014 – Shelley Fuld Nasso
Currently Viewing
Confirmation of Lycopene's Benefits Remains Elusive
March 06, 2014 – Deborah Tolmach Sugerman
Pipeline
March 08, 2014 – Lindsay Ray
Preserving Security with Electronic Health Portals
March 06, 2014 – Charlotte Huff
The "To Do" List to Pass On to Well-Meaning Friends
March 08, 2014 – Don Vaughan
Choosing Quality Care
March 08, 2014 – Len Lichtenfeld, MD
Mobile App Delivers Helpful Tips to Minimize Side Effects
March 08, 2014
Legislations Could Benefit Family Caregivers
March 08, 2014 – Lena Huang
Exercise Improves Joint Pain Associated with Aromatase Inhibitors
March 08, 2014 – Jon Garinn
Moving Beyond Cancer to Wellness
March 08, 2014
Breast Cancer Prevention Study Focuses on Anti-Hormone Therapy
March 08, 2014 – Jon Garinn
Correspondent Amy Robach Receives Treatment
February 28, 2014 – Lindsay Ray
No Link Between Fertility Treatment and Overall Risk of Childhood Cancer
March 07, 2014 – Katherine Lagomarsino
Alzheimer's Disease and Cancer
March 06, 2014 – Sonya Collins
Research Updates
February 28, 2014 – Elizabeth Whittington
Genetics Leading the Way in Lung Cancer Treatment
March 05, 2014 – Debu Tripathy, MD
Letters From Readers
March 08, 2014
For Many, Caregiving Leads to Advocacy
March 07, 2014 – Jane Hill
Calming Chronic Inflammation
March 07, 2014 – Erik Ness
Making the Most Out of Your Patient Portal
March 07, 2014 – Charlotte Huff
Disclosing a Cancer Diagnosis Takes Time and Tact
March 05, 2014 – Don Vaughan
National Guidelines Aim to Make Life Better After Cancer
March 07, 2014 – Katy Human
Research Reveals New Frontiers in Lung Cancer
March 06, 2014 – Heather L. Van Epps, PhD
Biomarkers Help Patients Make Better Medical Decisions
March 06, 2014 – Laura Beil
The Priority List: A Teacher's Final Quest to Discover Life's Greatest Lessons
March 08, 2014
What to Do When Radiation Causes Skin Damage
March 07, 2014 – Lacey Meyer

Confirmation of Lycopene's Benefits Remains Elusive

Lycopene has health benefits, but whether it prevents cancer has not been confirmed.

BY Deborah Tolmach Sugerman
PUBLISHED March 06, 2014

There's nothing quite as mouthwatering as a rich, savory tomato sauce topping off fresh pasta—unless it’s that quintessentially American summer treat, a slice of ice-cold watermelon. Though the foods differ, they share their cheerful red hue thanks to lycopene, a carotenoid pigment.

Carotenoids are the fat-soluble pigments found in numerous red, orange and yellow fruits and vegetables, some of which the body uses to make vitamin A. While the lycopene found in apricots, guavas and papayas is likely less familiar (and not a source of vitamin A), proponents say it, too, has major health benefits. And research suggests that lycopene’s effectiveness is boosted if eaten with fat because it dissolves better in fat than in water and is thus more easily absorbed by the body.

 

“If a chemist could make a lycopene derivative that was more potent, and still safe, that could be very useful.” — MICHAEL SPORN

Lycopene is thought to potentially lower the risk of heart disease, stroke and macular degeneration. However, the pigment’s potential to prevent and treat certain cancers has generated great interest.

On the cellular level, lycopene, like all carotenoids, has well-established antioxidant properties. Additionally, laboratory studies of prostate cancer cells have shown that lycopene promotes apoptosis (programmed cell death), interferes with cell proliferation, inhibits the expression of androgen (male hormone) receptors, and possibly affects the insulin-like growth factor 1 (IGF-1) receptor signaling pathways. (Higher-than-normal levels of IGF-1 could lead to increased cancer risk.) But what does this mean outside the laboratory?

“The epidemiologic [observational] studies tend to suggest that high consumption of lycopene or a high blood level of lycopene is associated with a lower risk of prostate cancer,” says Edward Giovannucci, a professor of nutrition and epidemiology at Harvard School of Public Health in Boston.

However, these studies need to be interpreted with caution, because numerous factors can affect outcomes, including weight, diet and geographic settings. And the Food and Drug Administration (FDA) has found no credible evidence to support an association between lycopene intake and reduced risk of cancer.

Moreover, epidemiologic studies don’t tell the whole story; interventional studies are also necessary. For instance, it is possible that those who consume more lycopene also have other lifestyle habits that account for their lower cancer risk, pointing to a need for further studies.

Still, Giovannucci says epidemiologic and interventional studies are very different and not comparable, and that “in the era of widespread PSA screening, many prostate cancers that are diagnosed are indolent and at a relatively early stage. Thus, the potential beneficial influence of lycopene has been diluted.”

Lycopene supplements are generally regarded as safe, but, like all nutritional supplements, lycopene is not regulated by the FDA, and quality and consistency among brands varies.

Whether in foods or supplements, lycopene is not very potent, according to Michael Sporn, a professor of medicine at Dartmouth College’s Geisel School of Medicine in Hanover, N.H. “So one would need to eat a huge number of tomatoes or ingest something like a gram a day of pure lycopene in order for it to be clinically useful. We have no information about the safety of giving such a high dose to people.”

The bottom line: “Lycopene itself is simply not potent enough as a cancer-preventive agent to justify further clinical trials,” Sporn says.

“If a chemist could make a lycopene derivative that was more potent, and still safe, that could be very useful,” Sporn adds. “But that’s a long-term research project, and certainly not applicable to people in the short term.”

Perhaps one dietary component might not make much of a difference, but a combination of micronutrients could.

Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In